State of the Art Literature Review for EU MDR Compliance: How To Get It Right

Peter O’Blenis, President, Evidence Partners

Peter O’Blenis co-founded Evidence Partners in 2008 to develop leading edge technology that helps researchers deliver higher quality evidence, faster. The company’s core product, DistillerSR, is now the world’s most widely used literature review software.

As a pioneer in literature review automation, Peter’s passion for the subject has made him a sought-after speaker and resource. He has worked with over 250 research groups around the globe since 2001 and has published extensively on best practices and methodologies for using technology to improve the review process.

Peter previously held senior management roles with Oracle, WebGain, Mitel, and Flick Software. He holds an MBA from Queen’s University and a Bachelor of Computer Science from Carleton University.

Laurie Mitchell, President, Criterion Edge

Laurie Mitchell is the Founder and President of Criterion Edge, a global regulatory writing services firm serving the medical device, pharmaceutical, and biotech industries. She has over 25 years’ experience in clinical research, primarily in medical writing, pharmacovigilance management, and regulatory reporting. Prior to Criterion Edge, Laurie founded Mitchell Research Group, a successful site management organization, and acted as a Clinical Safety Consultant for Abbott Vascular for almost a decade.

Laurie brings extensive experience creating and training Data Safety Monitoring Boards and Clinical Event Committees and working with global cross-functional teams. Having worked for three of the four major medical device sponsors, she maintains expertise across many therapeutic areas. She holds a Master of Nursing as a Cardiopulmonary Clinical Nurse Specialist from the University of California, Los Angeles.